Alcon ANZ has appointed Penny Stewart, from Abbott Medical ANZ, to lead Alcon’s Surgical Franchise in Australia and New Zealand. Ms Stewart commenced her role at Alcon on 24 October, 2022. She joins Alcon ANZ following the appointment of Karen Fowler to Head of Commercial Operations and Strategic Projects, Alcon APAC Surgical.
Ms Stewart, who has over 25 years’ experience in medical device companies roles at Abbott, Phillips and Becton Dickinson, Roche Diagnostics and Biorad Laboratories, previously held the role of General Manager for Abbott’s Structural Heart franchise.
Chintan Desai, Vice-President of Alcon’s Surgical Franchise, APAC, welcomed Ms Stewart’s appointment. He said, “Alcon’s Surgical Franchise in Australia and New Zealand is one of the most important markets for the region, and I am delighted to welcome Penny to Alcon as the new Surgical Franchise Head and ANZ Country Manager. Penny’s appointment is critical for us in maintaining our leadership in surgical products and equipment and bringing new innovations to the Australia and New Zealand markets as part of our mission to help patients to see brilliantly.”
Penny’s appointment is critical for us in maintaining our leadership in surgical products and equipment and bringing new innovations to the Australia and New Zealand markets
Ms Stewart, who will be based in Alcon’s Macquarie Park offices in Sydney, holds a Bachelor of Science in Molecular Biology and a Masters in Applied Science in Pathology and Management. She began her career as a medical scientist in pathology and has held a range of sales, marketing and commercial leadership roles over the course of her career.
Commenting on her appointment Ms Stewart said, “Joining the world’s leading eye health company and heading Alcon’s surgical franchise in ANZ is a wonderful honour. I am looking forward to meeting with ANZ eye health care professionals and continuing the outstanding reputation that Alcon has for customer centricity and excellence in product innovation in ocular care and health”.
